1. Home
  2. BGT vs HRTX Comparison

BGT vs HRTX Comparison

Compare BGT & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BGT
  • HRTX
  • Stock Information
  • Founded
  • BGT 2004
  • HRTX 1983
  • Country
  • BGT United States
  • HRTX United States
  • Employees
  • BGT N/A
  • HRTX N/A
  • Industry
  • BGT Trusts Except Educational Religious and Charitable
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • BGT Finance
  • HRTX Health Care
  • Exchange
  • BGT Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • BGT 320.3M
  • HRTX 276.1M
  • IPO Year
  • BGT N/A
  • HRTX 1987
  • Fundamental
  • Price
  • BGT $12.51
  • HRTX $1.35
  • Analyst Decision
  • BGT
  • HRTX Strong Buy
  • Analyst Count
  • BGT 0
  • HRTX 2
  • Target Price
  • BGT N/A
  • HRTX $4.50
  • AVG Volume (30 Days)
  • BGT 107.2K
  • HRTX 2.6M
  • Earning Date
  • BGT 01-01-0001
  • HRTX 08-08-2025
  • Dividend Yield
  • BGT 10.77%
  • HRTX N/A
  • EPS Growth
  • BGT N/A
  • HRTX N/A
  • EPS
  • BGT N/A
  • HRTX N/A
  • Revenue
  • BGT N/A
  • HRTX $149,694,000.00
  • Revenue This Year
  • BGT N/A
  • HRTX $10.62
  • Revenue Next Year
  • BGT N/A
  • HRTX $12.99
  • P/E Ratio
  • BGT N/A
  • HRTX N/A
  • Revenue Growth
  • BGT N/A
  • HRTX 9.78
  • 52 Week Low
  • BGT $10.89
  • HRTX $1.04
  • 52 Week High
  • BGT $13.42
  • HRTX $2.68
  • Technical
  • Relative Strength Index (RSI)
  • BGT 51.65
  • HRTX 36.48
  • Support Level
  • BGT $12.37
  • HRTX $1.33
  • Resistance Level
  • BGT $12.55
  • HRTX $1.43
  • Average True Range (ATR)
  • BGT 0.10
  • HRTX 0.07
  • MACD
  • BGT 0.01
  • HRTX 0.02
  • Stochastic Oscillator
  • BGT 76.73
  • HRTX 45.45

About BGT BlackRock Floating Rate Income Trust

Blackrock Floating Rate Income Trust is a closed-end management investment company. Its investment objective is to provide a high level of current income. The company's secondary investment objective is to seek the preservation of capital. The Trust seeks to achieve its investment objectives by investing mainly, under normal conditions, at least 80% of its assets in floating and variable rate instruments of U.S. and non-U.S. issuers, including a substantial portion of its assets in floating and variable rate securities including senior secured floating rate loans made to corporate and other business entities.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: